$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

$icdiq Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000153702824000006 Filed on February 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$46.64M	$45.83M	$210.1M
YoY Change	-26.85%	-23.94%	12.53%
Cost Of Revenue	$30.82M	$31.47M	$130.3M
YoY Change	-17.74%	-12.46%	5.55%
Gross Profit	$15.82M	$14.36M	$79.85M
YoY Change	-39.84%	-40.93%	26.13%
Gross Profit Margin	33.92%	31.33%	38.01%
Selling, General & Admin	$4.337M	$5.683M	$24.50M
YoY Change	-35.53%	-26.32%	-1.25%
% of Gross Profit	27.41%	39.58%	30.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.83M	$11.06M	$43.50M
YoY Change	8.96%	3.09%	7.67%
% of Gross Profit	74.75%	77.0%	54.48%
Operating Expenses	$16.16M	$17.32M	$24.50M
YoY Change	140.27%	-6.04%	-1.25%
Operating Profit	-$343.0K	-$2.965M	-$3.717M
YoY Change	-103.93%	-150.5%	77.42%
Interest Expense	-$9.878M	-$9.763M	-$35.96M
YoY Change	13.29%	13.92%	21.57%
% of Operating Profit
Other Income/Expense, Net			-$585.0K
YoY Change
Pretax Income	-$9.217M	-$26.88M	-$39.67M
YoY Change	-92270.0%	664.13%	-44.53%
Income Tax	-$231.0K	-$931.0K	-$1.975M
% Of Pretax Income
Net Earnings	-$8.986M	-$25.95M	-$37.70M
YoY Change	-74983.33%	-849.81%	-42.29%
Net Earnings / Revenue	-19.27%	-56.62%	-17.94%
Basic Earnings Per Share	-$0.62		-$2.69
Diluted Earnings Per Share	-$0.62	-$1.70	-$2.69
COMMON SHARES
Basic Shares Outstanding	15.27M	14.08M	14.01M
Diluted Shares Outstanding	14.50M		14.01M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.944M	$5.565M	$5.565M
YoY Change	3.41%	4.49%	4.49%
Cash & Equivalents	$6.944M	$5.565M	$5.565M
Short-Term Investments
Other Short-Term Assets	$3.697M	$4.759M	$4.759M
YoY Change	369600.0%	475800.0%	-5.97%
Inventory	$1.570M	$1.557M	$1.557M
Prepaid Expenses
Receivables	$27.19M	$31.70M	$31.70M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$39.40M	$43.58M	$43.58M
YoY Change	-26.99%	-15.66%	-15.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$342.7M	$350.4M	$350.4M
YoY Change	-9.85%	-7.07%	-7.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.670M	$2.908M	$703.0K
YoY Change	11.76%	48.37%	-28.56%
Total Long-Term Assets	$345.4M	$351.1M	$351.1M
YoY Change	-9.37%	-7.13%	-7.13%
TOTAL ASSETS
Total Short-Term Assets	$39.40M	$43.58M	$43.58M
Total Long-Term Assets	$345.4M	$351.1M	$351.1M
Total Assets	$384.8M	$394.7M	$394.7M
YoY Change	-11.56%	-8.15%	-8.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.80M	$22.99M	$22.99M
YoY Change	-30.25%	-28.03%	-28.03%
Accrued Expenses	$6.378M	$16.37M	$11.76M
YoY Change	-52.93%	-7.03%	3.35%
Deferred Revenue	$614.0K	$578.0K
YoY Change	-55.12%	-42.37%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.525M	$1.226M	$1.226M
YoY Change	-26.36%	-50.66%	-50.66%
Total Short-Term Liabilities	$30.11M	$40.59M	$40.59M
YoY Change	-29.28%	-22.01%	-22.01%
LONG-TERM LIABILITIES
Long-Term Debt	$170.4M	$154.5M	$154.5M
YoY Change	3.95%	7.91%	7.91%
Other Long-Term Liabilities	$1.316M	$8.201M	$8.201M
YoY Change	101.84%	9.73%	9.73%
Total Long-Term Liabilities	$171.7M	$8.201M	$162.8M
YoY Change	26233.44%	9.73%	8.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.11M	$40.59M	$40.59M
Total Long-Term Liabilities	$171.7M	$8.201M	$162.8M
Total Liabilities	$211.3M	$213.1M	$213.1M
YoY Change	-3.67%	-0.89%	-0.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$445.8M	-$436.8M
YoY Change	11.7%	9.45%
Common Stock	$623.3M	$622.3M
YoY Change	0.75%	0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$173.4M	$181.6M	$181.6M
YoY Change
Total Liabilities & Shareholders Equity	$384.8M	$394.7M	$394.7M
YoY Change	-11.56%	-8.15%	-8.15%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$8.986M	-$25.95M	-$37.70M
YoY Change	-74983.33%	-849.81%	-42.29%
Depreciation, Depletion And Amortization	$11.83M	$11.06M	$43.50M
YoY Change	8.96%	3.09%	7.67%
Cash From Operating Activities	$11.00M	$7.474M	$61.02M
YoY Change	-18.87%	-48.03%	113.54%
INVESTING ACTIVITIES
Capital Expenditures	$9.974M	$4.020M	$40.66M
YoY Change	-47.05%	-80.64%	-5.56%
Acquisitions
YoY Change
Other Investing Activities	$1.783M	$1.303M	$4.438M
YoY Change	138.37%	-34.65%	-6.43%
Cash From Investing Activities	-$8.191M	-$2.717M	-$36.22M
YoY Change	-54.71%	-85.52%	-5.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.429M	-5.236M	-24.57M
YoY Change	-124.15%	-343.88%	-325.11%
NET CHANGE
Cash From Operating Activities	11.00M	7.474M	61.02M
Cash From Investing Activities	-8.191M	-2.717M	-36.22M
Cash From Financing Activities	-1.429M	-5.236M	-24.57M
Net Change In Cash	1.379M	-479.0K	239.0K
YoY Change	-0.72%	-78.62%	-79.85%
FREE CASH FLOW
Cash From Operating Activities	$11.00M	$7.474M	$61.02M
Capital Expenditures	$9.974M	$4.020M	$40.66M
Free Cash Flow	$1.025M	$3.454M	$20.37M
YoY Change	-119.42%	-154.13%	-240.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1653648
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001537028
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q4	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36590
CY2023	dei	Entity Registrant Name EntityRegistrantName	INDEPENDENCE CONTRACT DRILLING, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	20475 State Highway 249
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77070
CY2023	dei	City Area Code CityAreaCode	281
CY2023	dei	Local Phone Number LocalPhoneNumber	598-1230
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023	dei	Trading Symbol TradingSymbol	ICD
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	28977915
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15266773
CY2023	dei	Auditor Firm AuditorFirmId	659
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2023	dei	Auditor Name AuditorName	MOSS ADAMS, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5565000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5326000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31695000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39775000
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1557000
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1508000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	325000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4759000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4736000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	43576000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	51670000
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	348193000
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	376084000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2908000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1960000
CY2023Q4	us-gaap	Assets Assets	394677000
CY2022Q4	us-gaap	Assets Assets	429714000
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1226000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2485000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	22990000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31946000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16371000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17608000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40587000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52039000
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	154549000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	143223000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9761000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12266000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8201000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7474000
CY2023Q4	us-gaap	Liabilities Liabilities	213098000
CY2022Q4	us-gaap	Liabilities Liabilities	215002000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14523124
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13698851
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14425864
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13613759
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	144000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	136000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	622169000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	617606000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-436794000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399097000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	97260
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	85092
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3940000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3933000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	181579000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	214712000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	394677000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	429714000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210106000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186710000
CY2023	us-gaap	Direct Operating Costs DirectOperatingCosts	130253000
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	123399000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24499000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24809000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43543000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	40443000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14905000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	350000
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-38000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	196000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-585000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	213823000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	188805000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3717000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2095000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-35955000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-29575000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	4265000
CY2022	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10765000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39672000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71517000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1975000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6196000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37697000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65321000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.01
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14012000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14012000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13026000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13026000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-9000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3038000
CY2022	icd	Stock Issued During Period Value Restructuring StockIssuedDuringPeriodValueRestructuring	9163000
CY2022	icd	Adjustments To Additional Paid In Capital Extinguishment Of Derivative AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivative	69232000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3390000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65321000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	214712000
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-668000
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5239000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37697000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	181579000
CY2023	us-gaap	Profit Loss ProfitLoss	-37697000
CY2022	us-gaap	Profit Loss ProfitLoss	-65321000
CY2023	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	43543000
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	40443000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14905000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	350000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5671000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4644000
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-38000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	196000
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	25029000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	15859000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4140000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5565000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5326000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	111000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	346000
CY2023	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	8534000
CY2022	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	6714000
CY2022	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	4265000
CY2022	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10765000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2505000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6771000
CY2023	icd	Non Cash Cost To Obtain Revenue Contract NonCashCostToObtainRevenueContract	585000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1177000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	256000
CY2023	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-6318000
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	17820000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	249000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	365000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1380000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-266000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3058000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10325000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	61022000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28577000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40655000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43047000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4438000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4552000
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	191000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36217000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38304000
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	157500000
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	15000000
CY2022	icd	Repayments Of Term Loan Facility RepaymentsOfTermLoanFacility	139076000
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	34672000
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	5589000
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40983000
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	78000
CY2022	icd	Payments Of Merger Consideration PaymentsOfMergerConsideration	2902000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3038000
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	7000
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	668000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2580000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5811000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24566000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10913000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	239000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1186000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5326000
CY2022Q1	icd	Market Price Of Oil MarketPriceOfOil	123.64
CY2024Q1	icd	Market Price Of Oil MarketPriceOfOil	78.72
CY2022Q3	icd	Natural Gas Price NaturalGasPrice	9.85
CY2022Q4	icd	Natural Gas Price NaturalGasPrice	3.52
CY2023Q4	icd	Natural Gas Price NaturalGasPrice	2.58
CY2024Q1	icd	Natural Gas Price NaturalGasPrice	1.58
CY2023Q4	icd	Percentage Of Operating Fleet Classified As300 Series Rigs PercentageOfOperatingFleetClassifiedAs300SeriesRigs	0.90
CY2023Q1	icd	Percentage Of Operating Fleet Classified As300 Series Rigs PercentageOfOperatingFleetClassifiedAs300SeriesRigs	0.50
CY2023Q4	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	14700000
CY2023Q4	icd	Number Of Rigs Marketed Fleet NumberOfRigsMarketedFleet	26
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	300000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2023Q4	icd	Number Of Field Locations NumberOfFieldLocations	6
CY2022Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69200000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10800000
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0
CY2022	icd	Fair Value Assets Level Transfers Amount FairValueAssetsLevelTransfersAmount	0
CY2023	icd	Fair Value Assets Level Transfers Amount FairValueAssetsLevelTransfersAmount	0
CY2023	icd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	578000
CY2022	icd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	1158000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the balance sheet date, and the reported amounts of revenues and expenses recognized during the reporting period. Actual results could differ from these estimates. Significant estimates made by management include depreciation of property, plant and equipment, impairment of property, plant and equipment and assets held for sale, and the collectability of accounts receivable.</p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210106000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186710000
CY2023	icd	Accounts Receivable Payment Terms AccountsReceivablePaymentTerms	P30D
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	0
CY2023Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	31380000
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	39732000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	578000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1158000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1158000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	542000
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	578000
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	578000
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	500000
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	300000
CY2023	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	2300000
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2100000
CY2022	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	3300000
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3600000
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	600000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1086000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	747000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7107000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5697000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	608000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	577000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1878000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1682000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	278000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	387000
CY2023	icd	Finance Lease Cost FinanceLeaseCost	2156000
CY2022	icd	Finance Lease Cost FinanceLeaseCost	2069000
CY2023	us-gaap	Lease Cost LeaseCost	10957000
CY2022	us-gaap	Lease Cost LeaseCost	9090000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	921000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	732000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	278000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	373000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2580000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5811000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2106000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	153000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2161000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	4440000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2205000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	976000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	934000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1375000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	373000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2309000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1124000
CY2023Q4	icd	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	6238000
CY2022Q4	icd	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	7307000
CY2023Q4	icd	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	1829000
CY2022Q4	icd	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	1994000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4409000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5313000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1226000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2485000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1659000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1599000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2885000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4084000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0875
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1086
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0825
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0812
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1086000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1414000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	516000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1138000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	401000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	634000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	370000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	285000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2658000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3186000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	349000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	301000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2309000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2885000
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1557000
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1508000
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	6238000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	7307000
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	625416000
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	629888000
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	277223000
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	253804000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16371000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17608000
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	348193000
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	376084000
CY2023	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	28500000
CY2022	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	23300000
CY2023	us-gaap	Depreciation Depreciation	43500000
CY2022	us-gaap	Depreciation Depreciation	40400000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3502000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3796000
CY2023Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	467000
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	283000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	790000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	657000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4759000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4736000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6625000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6908000
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2996000
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3002000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	578000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1003000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2124000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3621000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	101000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	934000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000
CY2023Q4	icd	Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights	2054000
CY2022Q4	icd	Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights	1826000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1035000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	396000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	2358000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5084000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	804000
CY2023	icd	Change In Property Plant And Equipment Purchases In Accounts Payable ChangeInPropertyPlantAndEquipmentPurchasesInAccountsPayable	-8093000
CY2022	icd	Change In Property Plant And Equipment Purchases In Accounts Payable ChangeInPropertyPlantAndEquipmentPurchasesInAccountsPayable	11686000
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	2161000
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	4440000
CY2023	icd	Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets	513000
CY2022	icd	Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets	281000
CY2023	icd	Transfer Of Assets From Held And Used To Held For Sale TransferOfAssetsFromHeldAndUsedToHeldForSale	0
CY2022	icd	Transfer Of Assets From Held And Used To Held For Sale TransferOfAssetsFromHeldAndUsedToHeldForSale	325000
CY2022	icd	Initial Embedded Derivative Liability Upon Issuance Of Convertible Notes InitialEmbeddedDerivativeLiabilityUponIssuanceOfConvertibleNotes	75733000
CY2022	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69232000
CY2022	us-gaap	Stock Issued1 StockIssued1	9163000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2885000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4084000
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	187594000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	186061000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	31819000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	40353000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1226000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2485000
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	154549000
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	143223000
CY2023Q4	icd	Long Term Debt Gross Maturity Year One LongTermDebtGrossMaturityYearOne	14000000
CY2023Q4	icd	Long Term Debt Gross Maturity Year Two LongTermDebtGrossMaturityYearTwo	9000000
CY2023Q4	icd	Long Term Debt Gross Maturity Year Three LongTermDebtGrossMaturityYearThree	161709000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	184709000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
CY2023Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
	icd	Repayment Of Accrued Interest On Notes RepaymentOfAccruedInterestOnNotes	200000
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
CY2023Q3	icd	Repayment Of Accrued Interest On Notes RepaymentOfAccruedInterestOnNotes	400000
CY2023Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5000000.0
CY2023Q4	icd	Repayment Of Accrued Interest On Notes RepaymentOfAccruedInterestOnNotes	200000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5000000.0
CY2023Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5000000.0
CY2023Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5000000.0
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	18500000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6700000
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	530000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	575000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	530000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	575000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3285000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7480000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	780000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	709000
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-2505000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-6771000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1975000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6196000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8331000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15019000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	232000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3140000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1200000
CY2023	icd	Income Tax Reconciliation Debt Discount IncomeTaxReconciliationDebtDiscount	1408000
CY2022	icd	Income Tax Reconciliation Debt Discount IncomeTaxReconciliationDebtDiscount	7629000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	435000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1518000
CY2023	icd	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount	1141000
CY2022	icd	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount	873000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1975000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6196000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.050
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087
CY2023Q4	icd	Deferred Tax Assets Merger Related Expenses DeferredTaxAssetsMergerRelatedExpenses	808000
CY2022Q4	icd	Deferred Tax Assets Merger Related Expenses DeferredTaxAssetsMergerRelatedExpenses	894000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1328000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1349000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	128000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	613000
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	133000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	228000
CY2023Q4	icd	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	14855000
CY2022Q4	icd	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	8024000
CY2023Q4	icd	Deferred Tax Asset Right Of Use Asset DeferredTaxAssetRightOfUseAsset	533000
CY2022Q4	icd	Deferred Tax Asset Right Of Use Asset DeferredTaxAssetRightOfUseAsset	255000
CY2023Q4	icd	Deferred Tax Asset Debt Instruments DeferredTaxAssetDebtInstruments	1666000
CY2022Q4	icd	Deferred Tax Asset Debt Instruments DeferredTaxAssetDebtInstruments	2026000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	97112000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	96142000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	116563000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	109531000
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	794000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	845000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	43088000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	41937000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	509000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	222000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	44391000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	43004000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81933000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78793000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	9761000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12266000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	448600000
CY2023Q4	icd	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	134100000
CY2023Q4	icd	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	314500000
CY2023	icd	Operating Loss Carryforwards Expiration Amount OperatingLossCarryforwardsExpirationAmount	94200000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5671000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4644000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	97260
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-37697000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-65321000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.01
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14012000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13026000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14012000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13026000
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	39748000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31362000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	3400000
CY2023	us-gaap	Payments For Deposits PaymentsForDeposits	100000
CY2023Q4	icd	Employment Agreement Number Of Employees EmploymentAgreementNumberOfEmployees	6
CY2023	icd	Employment Agreement Term EmploymentAgreementTerm	P3Y
CY2023Q4	icd	Employment Agreement Minimum Annual Cash Compensation EmploymentAgreementMinimumAnnualCashCompensation	2100000
CY2023Q4	icd	Employment Agreement Severance Clause Amount EmploymentAgreementSeveranceClauseAmount	5400000
CY2023Q4	icd	Employment Agreement Commitment Amount EmploymentAgreementCommitmentAmount	7700000
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5300000
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	78900000
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	icd	Investors Rights Agreement Principal Amount InvestorsRightsAgreementPrincipalAmount	25000000.0
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	icd	Number Of Additional Representative To Be Appointed As Individual Director NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q2	icd	Number Of Directors NumberOfDirectors	6
CY2022Q3	icd	Number Of Directors NumberOfDirectors	7
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001537028-24-000006-index-headers.html	Edgar Link	pending
0001537028-24-000006-index.html	Edgar Link	pending
0001537028-24-000006.txt	Edgar Link	pending
0001537028-24-000006-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icd-20231231.xsd	Edgar Link	pending
icd-20231231x10k.htm	Edgar Link	pending
icd-20231231xex23d1.htm	Edgar Link	pending
icd-20231231xex23d2.htm	Edgar Link	pending
icd-20231231xex31d1.htm	Edgar Link	pending
icd-20231231xex31d2.htm	Edgar Link	pending
icd-20231231xex32d2.htm	Edgar Link	pending
icd-20231231xex97d1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icd-20231231_cal.xml	Edgar Link	unprocessable
icd-20231231_def.xml	Edgar Link	unprocessable
icd-20231231_lab.xml	Edgar Link	unprocessable
icd-20231231_pre.xml	Edgar Link	unprocessable
icd-20231231x10k_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

2024 Q1 Form 10-K Financial Statement

#000153702824000006 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ Independence Contract Drilling, Inc. Stock $icdiq

2024 Q1 Form 10-K Financial Statement

#000153702824000006 Filed on February 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq